The European Medicines Agency is recommending approval of a new medicine for chronic hepatitis C in adults, Incivo (telaprevir). The developer is Janssen Pharmaceutical and the drug was approved by the FDA in May. ---Subscribe to MedNous to access this article--- Regulation & Policy
